Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.
Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal.
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
Endocannabinoids and Endocannabinoid-Related Mediators: Targets, Metabolism and Role In Neurological Disorders.
Effects of dextromethorphan on glial cell function: Proliferation, maturation, and protection from cytotoxic molecules.
PET in Multiple Sclerosis.
Multiple sclerosis: Natalizumab to fingolimod-the washout whitewash.
The need for randomization in animal trials: an overview of systematic reviews.
'It feels like someone is hammering my feet': Understanding pain and its management from the perspective of people with multiple sclerosis.
The secretome of mesenchymal stem cells: Potential implications for neuroregeneration.
Current and new directions in MRI in multiple sclerosis.
Myelin architecture: zippering membranes tightly together.
The gateway theory: bridging neural and immune interactions in the CNS.
B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation.
Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.
Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
Frequent laboratory abnormalities in CIDP patients.
Progress in multiple sclerosis genetics.
Differential Pro-Inflammatory Responses of Astrocytes and Microglia Involve STAT3 Activation in Response to 1800 MHz Radiofrequency Fields.
Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview.
Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
Extracellular vesicles round off communication in the nervous system.
Is customized vestibular rehabilitation effective in patients with multiple sclerosis? A randomized controlled trial.
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Pages
« first
‹ previous
…
469
470
471
472
473
474
475
476
477
…
next ›
last »